Latest Islets of Langerhans Stories
GORDONSVILLE, Va., Nov.
St. Jude Children's Research Hospital study results suggest new approaches for preventing disease MEMPHIS, Tenn., Oct. 8 /PRNewswire-USNewswire/ -- St.
MINNEAPOLIS, Sept. 10 /PRNewswire/ -- Exsulin Corporation today announced the start of a phase II human clinical trial of Exsulin(TM), a peptide drug product aimed at restoring insulin production in people with diabetes mellitus.
For years researchers have been searching for a way to treat diabetics by reactivating their insulin-producing beta cells, to no avail. Now, they may be one step closer.
MINNEAPOLIS, June 26 /PRNewswire-USNewswire/ -- Receiving more than $80,000 from Minnesota and Wisconsin Multiple District Lions Clubs over the past years, Spring Point Project, a non profit organization developing pig donors for pancreatic islet transplantation to cure diabetes, is attending the Lions Clubs International 92nd Convention.
Scientists at Burnham Institute for Medical Research (Burnham) and the University of California San Diego (UC San Diego) School of Medicine have demonstrated in mice that transplanted pancreatic precursor cells are protected from the immune system when encapsulated in polytetrafluorethylene (PTFE).
More than five years ago, Dr. Lawrence C.B. Chan and colleagues in his Baylor College of Medicine laboratory cured mice with type 1 diabetes by using a gene to induce liver cells to make insulin.
Cutting-edge DNA testing technology provided by GeneSeek Inc. LINCOLN, Neb., Feb.
WYNNEWOOD, Pa., Jan. 27 /PRNewswire/ -- A study released today in Endocrine Practice (2008;14:1075), the leading peer-reviewed journal for practicing endocrinologists in the US and 65 countries, reports a ground breaking discovery with the potential to reverse type 1 and 2 diabetes.
Early attempts at islet cell transplantation to treat diabetes date to the nineteenth century, decades before the discovery of insulin in the 1930s.